Remove topics medical-marijuana
article thumbnail

Around the IP Blogs

The IPKat

Miscellaneous IPTango discussed a recent transparency report published by Mercado Libre, divided into four main topics: user information requests (section one), product security and quality (section two), protection of IP rights (section three), and privacy matters (section four).

article thumbnail

IP and Cannabis: The Current Landscape

Fish & Richardson Trademark & Copyright Thoughts

ii] While marijuana remains a Schedule I controlled substance under federal law, a majority of states have legalized consumption of certain cannabis products under certain conditions. For more information about any topic herein, please see our October 20, 2020 webinar, “ IP and Cannabis: The Current Landscape ,” or contact your Fish attorney.

IP 52
article thumbnail

Global Advertising Lawyers Alliance (GALA) Webinar – “Hot Topics in Advertising Law in North America”

43(B)log

Ongoing consumer class actions regarding pesticide in supposedly “organic” medical cannabis. Privacy is also a hot topic: CCPA in California is now effective [or as Eric Goldman might say, it’s in effect]. Black stamps on products that qualify; also new guidelines on medical marijuana.